Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,166.00
0.00 (0.00%)
Last updated: Aug 8, 2025
Market Cap99.11B
Revenue (ttm)107.87B
Net Income (ttm)1.92B
Shares Out85.00M
EPS (ttm)47.45
PE Ratio24.57
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume124,612
Average Volume494,640
Open1,166.00
Previous Close1,166.00
Day's Range1,163.00 - 1,179.00
52-Week Range1,003.00 - 2,060.00
Beta0.49
RSI41.08
Earnings Daten/a

About Hwail Pharmaceutical

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 061250
Full Company Profile

Financial Performance

In 2016, Hwail Pharmaceutical's revenue was 111.52 billion, an increase of 5.08% compared to the previous year's 106.13 billion. Earnings were 6.38 billion, an increase of 17.03%.

Financial Statements

News

There is no news available yet.